Our Services
Medical Information
Helpful Resources
Published on: 5/16/2026
Shilajit and PCOS Insulin Sensitivity: What the Research Shows
Shilajit may help improve insulin sensitivity in women with PCOS through three key mechanisms: antioxidant activity, mitochondrial support, and enhanced mineral absorption. Animal studies and small human trials have shown reductions in fasting glucose and improvements in insulin markers.
Key considerations:
Because PCOS symptoms overlap with many other hormonal and metabolic conditions—including thyroid disorders, insulin resistance, and adrenal issues—it's important to understand what's actually driving your symptoms before choosing a supplement strategy. Guessing can waste time and money, and delay effective treatment. Take a free, instant, online symptom check to clarify what may be behind your symptoms and get personalized guidance on your next steps.
Reviewed for medical accuracy: 07/10/2026
Understanding how Shilajit may influence insulin regulation in Polycystic Ovarian Syndrome (PCOS) can help you make informed choices about supplements and lifestyle strategies. This overview draws on peer-reviewed studies, traditional uses of Shilajit, and current understanding of PCOS-related insulin resistance. Always discuss any new supplement with your healthcare provider.
Shilajit is a sticky, tar-like substance found primarily in the Himalayas and parts of Central Asia. It's formed over centuries by the gradual decomposition of certain plants. Traditional Ayurvedic medicine uses Shilajit for energy, cognition, and longevity. Modern research has identified several components that could influence metabolic health:
PCOS affects up to 10% of reproductive-aged women worldwide. A key feature in many is insulin resistance:
Antioxidant and Anti-Inflammatory Effects
Mitochondrial Support
Nutrient Delivery and Mineral Balance
Modulation of Glucose-Regulating Enzymes
While direct human trials of Shilajit in PCOS are limited, we can extrapolate from related research:
While these findings are promising, high-quality randomized controlled trials in women with PCOS are still needed. The hormonal milieu in PCOS is complex; supplements that help general insulin resistance may not have identical effects within this syndrome.
Form and Quality
Dosage
Timing
Safety Profile
Interactions
Shilajit should complement, not replace, established PCOS therapies:
Dietary strategies
Physical activity
Stress management
Medical treatments
If you're experiencing symptoms like irregular periods, unexplained weight gain, or hormonal imbalances and want personalized guidance about your health, take our free AI symptom checker to understand what might be causing your concerns and whether you should seek medical care.
Although Shilajit is generally safe, always consult a healthcare professional if you experience:
Your doctor can help tailor dosing, review possible interactions with prescription medications, and ensure you're on the most effective plan for your PCOS management.
Shilajit offers a promising, natural avenue to support insulin sensitivity through antioxidant, mitochondrial, and mineral-supporting actions. While preliminary research is encouraging, rigorous clinical trials in women with PCOS are needed to confirm its effectiveness and optimal use. When combined with proven lifestyle changes and medical therapies, Shilajit for PCOS management could become a valuable component of a holistic treatment strategy. Always work closely with your healthcare provider to ensure safety and effectiveness in your journey toward better metabolic and reproductive health.
(References)
* Ghosh, S., et al. "Effects of processed Shilajit (BSK) on glucose, insulin, and lipid profile in high-fat diet and streptozotocin-induced diabetic rats." *Journal of Ethnopharmacology*, 262 (2020): 113203. PMID: 32668383. DOI: 10.1016/j.jep.2020.113203.
* Agarwal, S. P., et al. "Shilajit attenuates behavioral dysfunctions and restores the hyperglycemia-induced altered oxidative status in diabetic rats." *Phytotherapy Research*, 21.11 (2007): 1070-1077. PMID: 17768500. DOI: 10.1002/ptr.2223.
* Lizneva, D., et al. "Insulin resistance and the polycystic ovary syndrome." *Fertility and Sterility*, 106.6 (2016): 1334-1340. PMID: 27743604. DOI: 10.1016/j.fertnstert.2016.09.006.
* Spritzer, P. M., et al. "Mechanisms of insulin resistance in polycystic ovary syndrome." *Women's Health (London, England)*, 12.3 (2016): 295-306. PMID: 27288307. DOI: 10.1177/1745505716654276.
* Carrasco-Gallardo, C., et al. "Shilajit: An ancient panacea with modern relevance." *Journal of Ethnopharmacology*, 283 (2022): 114671. PMID: 34699566. DOI: 10.1016/j.jep.2021.114671.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.